{
    "medicine_id": "899f1b0c1653addc4b012bb105b43b95cb7b5ebd",
    "platform_id": "DB00236",
    "metadata": {
        "name": "Apo milrinone Injectable 1 mg ml Injection solution concentrate",
        "composition": "1 mg ml Pipobroman",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia",
            "contraindications": {
                "disease": "Symptoms of overdose include hematologic toxicity especially with chronic overdosage",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pipobroman is an antineoplastic agent Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pipobroman"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pipobroman"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Pipobroman"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pipobroman"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}